Table 2 EWAS DMP and DMR analyses of treatment responders at T2 (pre-treatment) vs T2 (post-treatment).
a: EWAS DMPs identified in the treatment responders at T2 compared with T1. | ||||||||
Responders T1 VS T2 | Gene | Probe | Chr | Position | m-value | FDR | Log Beta | Delta Beta |
PHF15 | cg07525804 | 5 | 133914473 | 3,83E + 07 | 0.2293 | 1,21E + 09 | 0.0368 | |
HMBS | cg27472151 | 11 | 118956135 | 5,91E + 07 | 0.2293 | 1,63E + 09 | 0.0211 | |
ARHGEF10 | cg14861020 | 8 | 1772352 | 1,03E + 08 | 0.2656 | 3,72E + 09 | 0.0258 | |
cg18890561 | 10 | 131988419 | 1,69E + 07 | 0.3276 | 8,21E + 09 | 0.0494 | ||
RAB27A | cg24809382 | 15 | 55582033 | 3,33E + 08 | 0.3930 | 0.0002 | 0.0070 | |
b: EWAS DMRs identified in the treatment responders at T2 compared with T1. | ||||||||
Responders T1 VS T2 | Gene | Chr: start-end | Area | L | Cluster (L) | p-value | FWER | Direction |
ARSG | 6: 291687-293285 | 0.557796234341063 | 7 | 7 | 3.15E-4 | 0.48 | T2 > T1 | |
SOX2OT | 17:6899207-6899577 | 0.540558928908835 | 8 | 20 | 3.13E-4 | 0.86 | T2 > T1 | |
BIN2 | 10:12335523-123356041 | 0.514183280465409 | 7 | 14 | 3.98E-4 | 0.91 | T2 > T1 | |
PARVB | 3:1954890-195490033 | 0.490337023581752 | 7 | 9 | 4.49E-4 | 0.91 | T2 > T1 | |
LGR6 | 17:80545175-80545434 | 0.446370934234037 | 5 | 6 | 5.34E-4 | 0.98 | T2 > T1 | |